Not a good buy right now. For a beginner focused on long-term investing with $50,000-$100,000, MTX is currently a sell/avoid because the recent Chapter 11 reorganization filing and related talc liabilities create a major fundamental overhang that outweighs the modest technical and analyst support. The stock may still bounce in the short term, but based on the data provided, it is not a suitable long-term purchase at this time.
MTX is in a weak technical position. The MACD histogram is negative and still expanding lower, which points to persistent downside momentum. RSI_6 at 35.17 is near oversold but not yet a strong reversal signal. Moving averages are converging, which suggests indecision rather than a confirmed uptrend. Price at 74.46 is just above S1 support at 74.016 and below the pivot at 76.646, so the stock is trading in a fragile zone. The short-term pattern data suggests potential upside over the next day/week/month, but that is not enough to override the broader weakness and event risk.

["Seaport Research raised its price target to $90 from $85 and kept a Buy rating, citing improved confidence in growth momentum.", "The stock has a short-term statistical setup that suggests potential upside over the next day, week, and month.", "Price is near support, which could attract tactical buyers if sentiment stabilizes."]
["Minerals Technologies announced a Chapter 11 reorganization filing due to severe financial distress, which is the dominant negative catalyst.", "The company filed a reorganization plan involving a $450 million trust for talc-related claims and a $290 million charge for estimated costs.", "MACD is weakening and momentum remains negative.", "Hedge funds and insiders are neutral, showing no strong conviction from informed holders.", "No significant recent congress trading or influential insider/politician activity was reported.", "Options positioning is slightly bearish with limited volume conviction."]
No usable financial snapshot was provided because of a data error, so the latest quarter's revenue and earnings growth cannot be assessed directly. The only clear financial signal in the dataset is the severe distress implied by the Chapter 11 filing and the substantial restructuring-related charges, which indicates deteriorated financial health in the latest reported period. The latest quarter season was not provided.
Analyst sentiment is mixed but still supportive on paper: Seaport Research raised its target to $90 from $85 and maintained a Buy rating on 2026-05-04, saying confidence in growth momentum improved despite modest price and cost headwinds. Wall Street pros appear constructive on valuation and momentum before the restructuring news, but the Chapter 11 filing has likely overtaken that thesis and makes the bullish analyst view less reliable right now.